SNT 8.33% 3.9¢ syntara limited

Ann: Ceasing to be a substantial holder from Arix Bioscience, page-36

  1. MrQ
    5,148 Posts.
    lightbulb Created with Sketch. 272
    The adult methodology had problems. FDA basically said go back and re-do the adult work. 7 years 9 months later here we are. More detailed than that of course but you get the drift.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.